Loading the map…

Other letting and operating of own or leased real estate · London

My Cell

My Cell Ltd

ActiveLatest figures: 2025Abridged accountsCompany only3 years on the register

Private limited company registered in London, classed under “Other letting and operating of own or leased real estate”.

Headline figures

FY to Jun 2025 · Company only

Turnover

For subscribers

Profit after tax

—

Not filed: small-company exemption

Net assets

For subscribers

Cash

For subscribers

Employees

For subscribers

What the numbers say

1 finding from the figures, in plain English

Written by rules from the figures on this page. Not a forecast or a credit opinion.

History

Pro
£20242025
Profit after tax—
Turnover
Net assets
Cash
Employees

Every figure for all 2 years

“—” means we did not find the figure in a source; it is never filled with an estimate.

Balance sheet and ratios

From the filed balance sheets · £

Balance sheet20242025
Fixed assets
Current assets
Creditors due within a year
Net current assets
Net assets
Ratios
Current ratioCurrent assets for every £1 owed within a year
Creditors to assetsEverything owed to creditors as a share of fixed plus current assets

5 balance-sheet lines and 2 ratios, every year

A ratio appears only for years where every line it needs was filed. Lines are as tagged in the accounts; nothing is added up or estimated.

Questions people ask

›What does My Cell do?

Private limited company registered in London, classed under “Other letting and operating of own or leased real estate”.

›How much turnover does My Cell make?

Answered in the full report

›Is My Cell profitable?

My Cell's profit isn't public: small companies may file without a profit and loss account.

›How many people work at My Cell?

Answered in the full report

›Where is My Cell based?

Its registered office is C/O Getground, 1, Lyric Square, London, W6 0NB, in London.

›When was My Cell founded?

My Cell Ltd was incorporated on 9 June 2023.

›Is My Cell still trading?

The register lists My Cell Ltd as active.